why choose us

First received: May 09, 2023

Clinical Trial: Arginine Replacement Therapy in COVID-19

Study Status: Completed

Recruit Status: RECRUITING

Condition: COVID-19

Study Type: INTERVENTIONAL


Official Title: Prospective Open-Label Pilot Study of Arginine Replacement Therapy in Children Hospitalized With COVID-19

Brief Summary: The purpose of this study is to investigate if receiving doses of arginine (a protein in the body) will improve mitochondria function in children with COVID-19.The study will be performed in Children's Healthcare of Atlanta, Egleston campus.Patients will be randomized to receive one of three doses of arginine three times a day for five days or at discharge whichever comes first.

Read more